Reckitt Benckiser launches heartburn specialist Gaviscon
Reckitt Benckiser India launched its heartburn (acidity) reflux medicine Gaviscon nationally to strengthen the healthcare portfolio.
By PTI | Updated:
NEW DELHI: FMCG firm, Reckitt Benckiser India on Wednesday launched its heartburn (acidity) reflux medicine Gaviscon nationally to strengthen the healthcare portfolio.
Commenting on the launch, Reckitt Benckiser India Managing Director Akhil Chandra said: "Our focus in India is to further build and strengthen our healthcare portfolio. The national launch of one of our internationally established powerbrands and heartburn specialist - Gaviscon is one such step towards our goal."
The company in a statement said Gaviscon is amongst the 19 powerbrands in the Reckitt Benckiser portfolio.
"We will support the launch with a strong detailing outreach across 40 key cities in India with the help of our in-house team of experts from healthcare industry," Chandra added.
Commenting on the launch, Reckitt Benckiser India Managing Director Akhil Chandra said: "Our focus in India is to further build and strengthen our healthcare portfolio. The national launch of one of our internationally established powerbrands and heartburn specialist - Gaviscon is one such step towards our goal."
The company in a statement said Gaviscon is amongst the 19 powerbrands in the Reckitt Benckiser portfolio.
"We will support the launch with a strong detailing outreach across 40 key cities in India with the help of our in-house team of experts from healthcare industry," Chandra added.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
Related Articles
Former Reckitt Benckiser CMD CM Sethi passes awayADVERTISEMENT
